APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Reverse Logistics Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Reverse Logistics Service Market Outlook and Growth Opportunities 2026

6 January 2026197 pages

Choose your research edition.

Industry ResearchPharmaceutical Reverse Logistics Service Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Reverse Logistics Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Reverse Logistics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Reverse Logistics Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Reverse Logistics Service Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pharmaceutical Reverse Logistics Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Reverse Logistics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Reverse Logistics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Reverse Logistics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Reverse Logistics Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Reverse Logistics Service market include UPS Healthcare, FedEx, ICSConnect (Cencora), Inmar, PharmaLink, Pharma Logistics, SF Express, AWL India and Omni Logistics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical Reverse Logistics Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Reverse Logistics Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Reverse Logistics Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Reverse Logistics Service market.

Pharmaceutical Reverse Logistics Service Segment by Company

UPS Healthcare

FedEx

ICSConnect (Cencora)

Inmar

PharmaLink

Pharma Logistics

SF Express

AWL India

Omni Logistics

Globalink Logistics

Airpharm

Returns Logistics International

Hanzo Logistics

Pharmax Returns

Pharmaceutical Reverse Logistics Service Segment by Type

On-site Service

Off-site Service

Pharmaceutical Reverse Logistics Service Segment by Application

Pharmaceutical

Biopharmaceutical

Pharmaceutical Reverse Logistics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Reverse Logistics Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Reverse Logistics Service key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Reverse Logistics Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Reverse Logistics Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Reverse Logistics Service significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Reverse Logistics Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Reverse Logistics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Reverse Logistics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Reverse Logistics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Reverse Logistics Service industry.

Chapter 3: Detailed analysis of Pharmaceutical Reverse Logistics Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Reverse Logistics Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Reverse Logistics Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Reverse Logistics Service Industry Trends Table 2. Pharmaceutical Reverse Logistics Service Industry Drivers Table 3. Pharmaceutical Reverse Logistics Service Industry Opportunities and Challenges Table 4. Pharmaceutical Reverse Logistics Service Industry Restraints Table 5. Global Pharmaceutical Reverse Logistics Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Reverse Logistics Service Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Reverse Logistics Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Reverse Logistics Service Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Reverse Logistics Service Company, Product Type & Application Table 10. Global Pharmaceutical Reverse Logistics Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Reverse Logistics Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On-site Service Table 15. Significant Companies of Off-site Service Table 16. Global Pharmaceutical Reverse Logistics Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pharmaceutical Reverse Logistics Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pharmaceutical Reverse Logistics Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pharmaceutical Reverse Logistics Service Sales Value Share by Type (2021-2026) Table 20. Global Pharmaceutical Reverse Logistics Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceutical Table 22. Significant Companies of Biopharmaceutical Table 23. Global Pharmaceutical Reverse Logistics Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Pharmaceutical Reverse Logistics Service Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Pharmaceutical Reverse Logistics Service Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Pharmaceutical Reverse Logistics Service Sales Value Share by Application (2021-2026) Table 27. Global Pharmaceutical Reverse Logistics Service Sales Value Share by Application (2027-2032) Table 28. Global Pharmaceutical Reverse Logistics Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Pharmaceutical Reverse Logistics Service Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Pharmaceutical Reverse Logistics Service Sales Value Share by Region (2021-2026) Table 31. Global Pharmaceutical Reverse Logistics Service Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Pharmaceutical Reverse Logistics Service Sales Value Share by Region (2027-2032) Table 33. Global Pharmaceutical Reverse Logistics Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pharmaceutical Reverse Logistics Service Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Pharmaceutical Reverse Logistics Service Sales Value Market Share by Country (2021-2026) Table 36. Global Pharmaceutical Reverse Logistics Service Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Pharmaceutical Reverse Logistics Service Sales Value Market Share by Country (2027-2032) Table 38. UPS Healthcare Company Information Table 39. UPS Healthcare Business Overview Table 40. UPS Healthcare Pharmaceutical Reverse Logistics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. UPS Healthcare Pharmaceutical Reverse Logistics Service Product Portfolio Table 42. UPS Healthcare Recent Development Table 43. FedEx Company Information Table 44. FedEx Business Overview Table 45. FedEx Pharmaceutical Reverse Logistics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. FedEx Pharmaceutical Reverse Logistics Service Product Portfolio Table 47. FedEx Recent Development Table 48. ICSConnect (Cencora) Company Information Table 49. ICSConnect (Cencora) Business Overview Table 50. ICSConnect (Cencora) Pharmaceutical Reverse Logistics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. ICSConnect (Cencora) Pharmaceutical Reverse Logistics Service Product Portfolio Table 52. ICSConnect (Cencora) Recent Development Table 53. Inmar Company Information Table 54. Inmar Business Overview Table 55. Inmar Pharmaceutical Reverse Logistics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Inmar Pharmaceutical Reverse Logistics Service Product Portfolio Table 57. Inmar Recent Development Table 58. PharmaLink Company Information Table 59. PharmaLink Business Overview Table 60. PharmaLink Pharmaceutical Reverse Logistics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. PharmaLink Pharmaceutical Reverse Logistics Service Product Portfolio Table 62. PharmaLink Recent Development Table 63. Pharma Logistics Company Information Table 64. Pharma Logistics Business Overview Table 65. Pharma Logistics Pharmaceutical Reverse Logistics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Pharma Logistics Pharmaceutical Reverse Logistics Service Product Portfolio Table 67. Pharma Logistics Recent Development Table 68. SF Express Company Information Table 69. SF Express Business Overview Table 70. SF Express Pharmaceutical Reverse Logistics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. SF Express Pharmaceutical Reverse Logistics Service Product Portfolio Table 72. SF Express Recent Development Table 73. AWL India Company Information Table 74. AWL India Business Overview Table 75. AWL India Pharmaceutical Reverse Logistics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. AWL India Pharmaceutical Reverse Logistics Service Product Portfolio Table 77. AWL India Recent Development Table 78. Omni Logistics Company Information Table 79. Omni Logistics Business Overview Table 80. Omni Logistics Pharmaceutical Reverse Logistics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Omni Logistics Pharmaceutical Reverse Logistics Service Product Portfolio Table 82. Omni Logistics Recent Development Table 83. Globalink Logistics Company Information Table 84. Globalink Logistics Business Overview Table 85. Globalink Logistics Pharmaceutical Reverse Logistics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Globalink Logistics Pharmaceutical Reverse Logistics Service Product Portfolio Table 87. Globalink Logistics Recent Development Table 88. Airpharm Company Information Table 89. Airpharm Business Overview Table 90. Airpharm Pharmaceutical Reverse Logistics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Airpharm Pharmaceutical Reverse Logistics Service Product Portfolio Table 92. Airpharm Recent Development Table 93. Returns Logistics International Company Information Table 94. Returns Logistics International Business Overview Table 95. Returns Logistics International Pharmaceutical Reverse Logistics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Returns Logistics International Pharmaceutical Reverse Logistics Service Product Portfolio Table 97. Returns Logistics International Recent Development Table 98. Hanzo Logistics Company Information Table 99. Hanzo Logistics Business Overview Table 100. Hanzo Logistics Pharmaceutical Reverse Logistics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Hanzo Logistics Pharmaceutical Reverse Logistics Service Product Portfolio Table 102. Hanzo Logistics Recent Development Table 103. Pharmax Returns Company Information Table 104. Pharmax Returns Business Overview Table 105. Pharmax Returns Pharmaceutical Reverse Logistics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Pharmax Returns Pharmaceutical Reverse Logistics Service Product Portfolio Table 107. Pharmax Returns Recent Development Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Pharmaceutical Reverse Logistics Service Product Image Figure 2. Global Pharmaceutical Reverse Logistics Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Reverse Logistics Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Reverse Logistics Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On-site Service Image Figure 8. Off-site Service Image Figure 9. Global Pharmaceutical Reverse Logistics Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pharmaceutical Reverse Logistics Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pharmaceutical Reverse Logistics Service Sales Value Share by Type (2021-2032) Figure 12. Pharmaceutical Image Figure 13. Biopharmaceutical Image Figure 14. Global Pharmaceutical Reverse Logistics Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pharmaceutical Reverse Logistics Service Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical Reverse Logistics Service Sales Value Share by Application (2021-2032) Figure 17. Global Pharmaceutical Reverse Logistics Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Pharmaceutical Reverse Logistics Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Pharmaceutical Reverse Logistics Service Sales Value (2021-2032) & (US$ Million) Figure 20. North America Pharmaceutical Reverse Logistics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Pharmaceutical Reverse Logistics Service Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Pharmaceutical Reverse Logistics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Pharmaceutical Reverse Logistics Service Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Pharmaceutical Reverse Logistics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Pharmaceutical Reverse Logistics Service Sales Value (2021-2032) & (US$ Million) Figure 26. South America Pharmaceutical Reverse Logistics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Pharmaceutical Reverse Logistics Service Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Pharmaceutical Reverse Logistics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • On-site Service
  • Off-site Service
Applications
  • Pharmaceutical
  • Biopharmaceutical
Companies covered
  • UPS Healthcare
  • FedEx
  • ICSConnect (Cencora)
  • Inmar
  • PharmaLink
  • Pharma Logistics
  • SF Express
  • AWL India
  • Omni Logistics
  • Globalink Logistics
  • Airpharm
  • Returns Logistics International
  • Hanzo Logistics
  • Pharmax Returns

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Reverse Logistics Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Reverse Logistics Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Reverse Logistics Service Market Dynamics
  1. 2.1 Pharmaceutical Reverse Logistics Service Industry Trends
  2. 2.2 Pharmaceutical Reverse Logistics Service Industry Drivers
  3. 2.3 Pharmaceutical Reverse Logistics Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Reverse Logistics Service Industry Restraints
3 Pharmaceutical Reverse Logistics Service Market by Company
  1. 3.1 Global Pharmaceutical Reverse Logistics Service Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Reverse Logistics Service Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Reverse Logistics Service Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Reverse Logistics Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Reverse Logistics Service Company Product Type and Application
  6. 3.6 Global Pharmaceutical Reverse Logistics Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Reverse Logistics Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Reverse Logistics Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Reverse Logistics Service Market by Type
  1. 4.1 Pharmaceutical Reverse Logistics Service Type Introduction
  2. 4.1.1 On-site Service
  3. 4.1.2 Off-site Service
  4. 4.2 Global Pharmaceutical Reverse Logistics Service Sales Value by Type
  5. 4.2.1 Global Pharmaceutical Reverse Logistics Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmaceutical Reverse Logistics Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pharmaceutical Reverse Logistics Service Sales Value Share by Type (2021-2032)
5 Pharmaceutical Reverse Logistics Service Market by Application
  1. 5.1 Pharmaceutical Reverse Logistics Service Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Biopharmaceutical
  4. 5.2 Global Pharmaceutical Reverse Logistics Service Sales Value by Application
  5. 5.2.1 Global Pharmaceutical Reverse Logistics Service Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pharmaceutical Reverse Logistics Service Sales Value by Application (2021-2032)
  7. 5.2.3 Global Pharmaceutical Reverse Logistics Service Sales Value Share by Application (2021-2032)
6 Pharmaceutical Reverse Logistics Service Regional Value Analysis
  1. 6.1 Global Pharmaceutical Reverse Logistics Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Reverse Logistics Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Reverse Logistics Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Reverse Logistics Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Reverse Logistics Service Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Reverse Logistics Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Reverse Logistics Service Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Reverse Logistics Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Reverse Logistics Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Reverse Logistics Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Reverse Logistics Service Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Reverse Logistics Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Reverse Logistics Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Reverse Logistics Service Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Reverse Logistics Service Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Reverse Logistics Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Reverse Logistics Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Reverse Logistics Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Reverse Logistics Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Reverse Logistics Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Reverse Logistics Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Reverse Logistics Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 UPS Healthcare
  2. 8.1.1 UPS Healthcare Company Information
  3. 8.1.2 UPS Healthcare Business Overview
  4. 8.1.3 UPS Healthcare Pharmaceutical Reverse Logistics Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 UPS Healthcare Pharmaceutical Reverse Logistics Service Product Portfolio
  6. 8.1.5 UPS Healthcare Recent Developments
  7. 8.2 FedEx
  8. 8.2.1 FedEx Company Information
  9. 8.2.2 FedEx Business Overview
  10. 8.2.3 FedEx Pharmaceutical Reverse Logistics Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 FedEx Pharmaceutical Reverse Logistics Service Product Portfolio
  12. 8.2.5 FedEx Recent Developments
  13. 8.3 ICSConnect (Cencora)
  14. 8.3.1 ICSConnect (Cencora) Company Information
  15. 8.3.2 ICSConnect (Cencora) Business Overview
  16. 8.3.3 ICSConnect (Cencora) Pharmaceutical Reverse Logistics Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ICSConnect (Cencora) Pharmaceutical Reverse Logistics Service Product Portfolio
  18. 8.3.5 ICSConnect (Cencora) Recent Developments
  19. 8.4 Inmar
  20. 8.4.1 Inmar Company Information
  21. 8.4.2 Inmar Business Overview
  22. 8.4.3 Inmar Pharmaceutical Reverse Logistics Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Inmar Pharmaceutical Reverse Logistics Service Product Portfolio
  24. 8.4.5 Inmar Recent Developments
  25. 8.5 PharmaLink
  26. 8.5.1 PharmaLink Company Information
  27. 8.5.2 PharmaLink Business Overview
  28. 8.5.3 PharmaLink Pharmaceutical Reverse Logistics Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PharmaLink Pharmaceutical Reverse Logistics Service Product Portfolio
  30. 8.5.5 PharmaLink Recent Developments
  31. 8.6 Pharma Logistics
  32. 8.6.1 Pharma Logistics Company Information
  33. 8.6.2 Pharma Logistics Business Overview
  34. 8.6.3 Pharma Logistics Pharmaceutical Reverse Logistics Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pharma Logistics Pharmaceutical Reverse Logistics Service Product Portfolio
  36. 8.6.5 Pharma Logistics Recent Developments
  37. 8.7 SF Express
  38. 8.7.1 SF Express Company Information
  39. 8.7.2 SF Express Business Overview
  40. 8.7.3 SF Express Pharmaceutical Reverse Logistics Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SF Express Pharmaceutical Reverse Logistics Service Product Portfolio
  42. 8.7.5 SF Express Recent Developments
  43. 8.8 AWL India
  44. 8.8.1 AWL India Company Information
  45. 8.8.2 AWL India Business Overview
  46. 8.8.3 AWL India Pharmaceutical Reverse Logistics Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AWL India Pharmaceutical Reverse Logistics Service Product Portfolio
  48. 8.8.5 AWL India Recent Developments
  49. 8.9 Omni Logistics
  50. 8.9.1 Omni Logistics Company Information
  51. 8.9.2 Omni Logistics Business Overview
  52. 8.9.3 Omni Logistics Pharmaceutical Reverse Logistics Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Omni Logistics Pharmaceutical Reverse Logistics Service Product Portfolio
  54. 8.9.5 Omni Logistics Recent Developments
  55. 8.10 Globalink Logistics
  56. 8.10.1 Globalink Logistics Company Information
  57. 8.10.2 Globalink Logistics Business Overview
  58. 8.10.3 Globalink Logistics Pharmaceutical Reverse Logistics Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Globalink Logistics Pharmaceutical Reverse Logistics Service Product Portfolio
  60. 8.10.5 Globalink Logistics Recent Developments
  61. 8.11 Airpharm
  62. 8.11.1 Airpharm Company Information
  63. 8.11.2 Airpharm Business Overview
  64. 8.11.3 Airpharm Pharmaceutical Reverse Logistics Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Airpharm Pharmaceutical Reverse Logistics Service Product Portfolio
  66. 8.11.5 Airpharm Recent Developments
  67. 8.12 Returns Logistics International
  68. 8.12.1 Returns Logistics International Company Information
  69. 8.12.2 Returns Logistics International Business Overview
  70. 8.12.3 Returns Logistics International Pharmaceutical Reverse Logistics Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Returns Logistics International Pharmaceutical Reverse Logistics Service Product Portfolio
  72. 8.12.5 Returns Logistics International Recent Developments
  73. 8.13 Hanzo Logistics
  74. 8.13.1 Hanzo Logistics Company Information
  75. 8.13.2 Hanzo Logistics Business Overview
  76. 8.13.3 Hanzo Logistics Pharmaceutical Reverse Logistics Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hanzo Logistics Pharmaceutical Reverse Logistics Service Product Portfolio
  78. 8.13.5 Hanzo Logistics Recent Developments
  79. 8.14 Pharmax Returns
  80. 8.14.1 Pharmax Returns Company Information
  81. 8.14.2 Pharmax Returns Business Overview
  82. 8.14.3 Pharmax Returns Pharmaceutical Reverse Logistics Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Pharmax Returns Pharmaceutical Reverse Logistics Service Product Portfolio
  84. 8.14.5 Pharmax Returns Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst